A recurrent tonsillitis

The Lancet

Volumn 381, Issue 9862, 2013, Pages 266-

  Fourage, Marie ^a   Bourguignat, Christophe ^b   Fermond, Bruno ^b   Delobel, Pierre ^c  

^a CIBAM   (France)

^b Cabinet Libéral   (France)

^c CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; C REACTIVE PROTEIN; CEFPODOXIME; METRONIDAZOLE;

ADULT; ANTIBIOTIC THERAPY; CASE REPORT; FUSOBACTERIUM INFECTION; FUSOBACTERIUM NECROPHORUM; HUMAN; LEUKOCYTE COUNT; MALE; NOTE; PRIORITY JOURNAL; RECURRENT INFECTION; RECURRENT TONSILLITIS; TONSILLITIS; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84872560652     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61606-7     Document Type: Article

References (5)

1. Riordan T. Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome. Clin Microbiol Rev 2007; 20: 622-59.
2. Jensen A, Hagelskjaer Kristensen L, Nielsen H, Prag J. Minimum requirements for a rapid and reliable routine identification and antibiogram of Fusobacterium necrophorum. Eur J Clin Microbiol Infect Dis 2008; 27: 557-63.
3. Gursoy UK, Könönen E, Uitto VJ. Intracellular replication of fusobacteria requires new actin filament formation of epithelial cells. APMIS 2008; 116: 1063-70.
4. Lemierre A. On certain septicaemias due to anaerobic organisms. Lancet 1936; 227: 701-03.
5. Klug TE, Henriksen JJ, Fuursted K, Ovesen T. Significant pathogens in peritonsillar abscesses. Eur J Clin Microbiol Infect Dis 2011; 30: 619-27.